Computational Prediction of Usutu Virus E Protein B Cell and T Cell Epitopes for Potential Vaccine Development

Scandinavian Journal of Immunology

Volumn 85, Issue 5, 2017, Pages 350-364

  Palanisamy, N ^a,b   Lennerstrand, J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; USUTU VIRUS E PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; PEPTIDE; PROTEIN BINDING; VACCINE;

ALLERGENICITY; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BLACK PERSON; FLAVIVIRIDAE; IC50; MOLECULAR DOCKING; NONHUMAN; PHYLOGENETIC TREE; PREDICTION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; T LYMPHOCYTE; USUTU VIRUS; AMINO ACID SEQUENCE; ANIMAL; BIOLOGY; CHEMISTRY; CLASSIFICATION; EPITOPE MAPPING; FLAVIVIRIDAE INFECTIONS; GENETICS; HUMAN; IMMUNOLOGY; JAPANESE ENCEPHALITIS VIRUS; METABOLISM; MOLECULAR MODEL; PHYLOGENY; PROCEDURES; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; COMPUTATIONAL BIOLOGY; ENCEPHALITIS VIRUSES, JAPANESE; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FLAVIVIRIDAE INFECTIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MODELS, MOLECULAR; PEPTIDES; PHYLOGENY; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; VACCINES; VIRAL ENVELOPE PROTEINS;

EID: 85018753766     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12544     Document Type: Article

References (69)

1. Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB. Phylogeny of the genus flavivirus. J Virol 1998;72:73–83.
2. Williams MC, Simpson DI, Haddow AJ, Knight EM. The isolation of West Nile virus from man and of Usutu virus from the bird-biting mosquito Mansonia aurites (Theobald) in the Entebbe area of Uganda. Ann Trop Med Parasitol 1964;58:367–74.
3. Bakonyi T, Gould EA, Kolodziejek J, Weissenböck H, Nowotny N. Complete genome analysis and molecular characterization of Usutu virus that emerged in Austria in 2001: comparison with the South African strain SAAR-1776 and other flaviviruses. Virology 2004;328:301–10.
4. Brinton MA, Fernandez AV, Dispoto JH. The 3′-nucleotides of flavivirus genomic RNA form a conserved secondary structure. Virology 1986;153:113–21.
5. Brinton MA, Dispoto JH. Sequence and secondary structure analysis of the 5′-terminal region of flavivirus genome RNA. Virology 1988;162:290–9.
6. Pijlman GP, Funk A, Kondratieva N et al. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 2008;4:579–91.
7. Ashraf U, Ye J, Ruan X, Wan S, Zhu B, Cao S. Usutu virus: an emerging flavivirus in Europe. Viruses 2015;7:219–38.
8. Weissenböck H, Kolodziejek J, Url A, Lussy H, Rebel-Bauder B, Nowotny N. Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe. Emerging Infect Dis 2002;8:652–6.
9. Chvala S, Bakonyi T, Bukovsky C et al. Monitoring of Usutu virus activity and spread by using dead bird surveillance in Austria, 2003-2005. Vet Microbiol 2007;122:237–45.
10. Mani P, Rossi G, Perrucci S, Bertini S. Mortality of Turdus merula in Tuscany. Sel Vet 1998;8:749–53.
11. Bakonyi T, Erdélyi K, Ursu K et al. Emergence of Usutu virus in Hungary. J Clin Microbiol 2007;45:3870–4.
12. Steinmetz HW, Bakonyi T, Weissenböck H et al. Emergence and establishment of Usutu virus infection in wild and captive avian species in and around Zurich, Switzerland–genomic and pathologic comparison to other central European outbreaks. Vet Microbiol 2011;148:207–12.
13. Hubálek Z, Rudolf I, Čapek M, Bakonyi T, Betášová L, Nowotny N. Usutu virus in blackbirds (Turdus merula), Czech Republic, 2011–2012. Transbound Emerg Dis 2014;61:273–6.
14. Lelli R, Savini G, Teodori L et al. Serological evidence of Usutu virus occurrence in north-eastern Italy. Zoonoses Public Health 2008;55:361–7.
15. Jöst H, Bialonski A, Maus D et al. Isolation of Usutu virus in Germany. Am J Trop Med Hyg 2011;85:551–3.
16. Barbic L, Vilibic-Cavlek T, Listes E et al. Demonstration of Usutu virus antibodies in horses. Croatia. Vector Borne Zoonotic Dis 2013;13:772–4.
17. Hubálek Z, Wegner E, Halouzka J et al. Serologic survey of potential vertebrate hosts for West Nile virus in Poland. Viral Immunol 2008;21:247–53.
18. Vázquez A, Ruiz S, Herrero L et al. West Nile and Usutu viruses in mosquitoes in Spain, 2008–2009. Am J Trop Med Hyg 2011;85:178–81.
19. Buckley A, Dawson A, Moss SR, Hinsley SA, Bellamy PE, Gould EA. Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK. J Gen Virol 2003;84:2807–17.
20. Buckley A, Dawson A, Gould EA. Detection of seroconversion to West Nile virus, Usutu virus and Sindbis virus in UK sentinel chickens. Virol J 2006;3:71.
21. Pecorari M, Longo G, Gennari W et al. First human case of Usutu virus neuroinvasive infection, Italy, August-September 2009. Euro Surveill 2009;14:e19446.
22. Vilibic-Cavlek T, Kaic B, Barbic L et al. First evidence of simultaneous occurrence of West Nile virus and Usutu virus neuroinvasive disease in humans in Croatia during the 2013 outbreak. Infection 2014;42:689–95.
23. Allering L, Jöst H, Emmerich P et al. Detection of Usutu virus infection in a healthy blood donor from south-west Germany, 2012. Euro Surveill 2012;17:e20341.
24. Cavrini F, Della Pepa ME, Gaibani P et al. A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid. J Clin Virol 2011;50:221–3.
25. Nikolay B, Weidmann M, Dupressoir A et al. Development of a Usutu virus specific real-time reverse transcription PCR assay based on sequenced strains from Africa and Europe. J Virol Methods 2014;197:51–4.
26. Blázquez AB, Escribano-Romero E, Martín-Acebes MA, Petrovic T, Saiz JC. Limited susceptibility of mice to Usutu virus (USUV) infection and induction of flavivirus cross-protective immunity. Virology 2015;482:67–71.
27. Beasley DW, Barrett AD. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 2002;76:13097–100.
28. Ashfaq UA, Ahmed B. De novo structural modeling and conserved epitopes prediction of Zika virus envelop protein for vaccine development. Viral Immunol 2016;29:1–8.
29. Alam A, Ali S, Ahamad S, Malik MZ, Ishrat R. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein. Immunology 2016;149:386–399. doi: 10.1111/imm.12656. [Epub ahead of print].
30. Chakraborty S, Chakravorty R, Ahmed M et al. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions. In Silico Biol 2010;10:235–46.
31. Hasan MA, Hossain M, Alam MJ. A computational assay to design an epitope-based peptide vaccine against Saint Louis Encephalitis virus. Bioinform Biol Insights 2013;7:347–55.
32. Hasan MA, Khan MA, Datta A, Mazumder MH, Hossain MU. A comprehensive immunoinformatics and target site study revealed the corner-stone toward Chikungunya virus treatment. Mol Immunol 2015;65:189–204.
33. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013;30:2725–9.
34. Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 2014;42:W320–4.
35. Gasteiger E, Hoogland C, Gattiker A et al. Protein identification and analysis tools on the ExPASy server. In: Walker JM, ed. The Proteomics Protocols Handbook. Totowa, NJ: Humana Press 2005: 571–607.
36. Sonnhammer EL, von Heijne G, Krogh A. A hidden markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol 1998;6:175–82.
37. Jones DT. Improving the accuracy of transmembrane protein topology prediction using evolutionary information. Bioinformatics 2007;23:538–44.
38. Ferrè F, Clote P. DiANNA 1.1: an extension of the DiANNA web server for ternary cysteine classification. Nucleic Acids Res 2006;34:W182–5.
39. Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 2007;8:4.
40. Muh HC, Tong JC, Tammi MT. AllerHunter: a SVM-pairwise system for assessment of allergenicity and allergic cross-reactivity in proteins. PLoS ONE 2009;4:e5861.
41. Wang J, Zhang D, Li J. PREAL: prediction of allergenic protein by maximum Relevance Minimum Redundancy (mRMR) feature selection. BMC Syst Biol 2013;7:S5–9.
42. Saha S, Raghava GPS. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 2006;65:40–8.
43. El-Manzalawy Y, Dobbs D, Honavar V. Predicting linear B-cell epitopes using string kernels. J Mol Recognit 2008;21:243–55.
44. Larsen JEP, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res 2006;2:2.
45. Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 1978;47:45–148.
46. Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 1985;55:836–9.
47. Karplus PA, Schulz GE. Prediction of chain flexibility in proteins – a tool for the selection of peptide antigens. Naturwissenschaften 1985;72:212–3.
48. Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990;276:172–4.
49. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986;25:5425–32.
50. Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M. Large-Scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 2007;8:424.
51. Peters B, Sette A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 2005;6:132.
52. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001;17:1236–7.
53. Biasini M, Bienert S, Waterhouse A et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 2014;42:W252–8.
54. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 2015;10:845–58.
55. Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER Suite: protein structure and function prediction. Nat Methods 2015;12:7–8.
56. Xu D, Zhang Y. Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys J 2011;101:2525–34.
57. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK – a program to check the stereochemical quality of protein structures. J App Cryst 1993;26:283–91.
58. Bui HH, Sidney J, Li W, Fusseder N, Sette A. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics 2007;8:361.
59. Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 2006;7:153.
60. Tynan FE, Borg NA, Miles JJ et al. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J Biol Chem 2005;280:23900–9.
61. Lamiable A, Thévenet P, Rey J, Vavrusa M, Derreumaux P, Tufféry P. PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex. Nucleic Acids Res 2016;44:W449–54.
62. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 2010;31:455–61.
63. Hubálek Z, Rudolf I, Nowotny N. Arboviruses pathogenic for domestic and wild animals. Adv Virus Res 2014;89:201–75.
64. Nikolay B. A review of West Nile and Usutu virus co-circulation in Europe: how much do transmission cycles overlap? Trans R Soc Trop Med Hyg 2015;109:609–18.
65. Dai L, Song J, Lu X et al. Structures of the Zika virus envelope protein and its complex with a Flavivirus broadly protective antibody. Cell Host Microbe 2016;19:696–704.
66. Cacciotti G, Caputo B, Selvaggi C et al. Variation in interferon sensitivity and induction between Usutu and West Nile (lineages 1 and 2) viruses. Virology 2015;485:189–98.
67. Martín-Acebes MA, Blázquez AB, Cañas-Arranz R et al. A recombinant DNA vaccine protects mice deficient in the alpha/beta interferon receptor against lethal challenge with Usutu virus. Vaccine 2016;34:2066–73.
68. Lobigs M, Diamond MS. Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex. Expert Rev Vaccines 2012;11:177–87.
69. Soria-Guerra RE, Nieto-Gomez R, Govea-Alonso DO, Rosales-Mendoza S. An overview of bioinformatics tools for epitope prediction: implications on vaccine development. J Biomed Inform 2015;53:405–14.